The most critically ill COVID-19 patients undergo a cytokine storm leading to poor prognosis & need urgent anti-inflammatory treatment/hospitalisation.
Cytokine Storm and Severity of COVID-19


The most critically ill COVID-19 patients undergo a cytokine storm leading to poor prognosis & need urgent anti-inflammatory treatment/hospitalisation.

AdipoGen Life Sciences offers a Selection of Antiviral Small Molecules as Potential Tools for in vitro Studies of COVID-19 (not for human use).

List of all AdipoGen Life Sciences’ Human ACE2 Antibodies

Anti-ACE2 (human), mAb (blocking) (AC384) (preservative free) is a monoclonal antibody that recognises human ACE2 and blocks its binding to SARS-Cov-2.

AdipoGen’s SARS-CoV-2 Inhibitor Screening Set has been developed as a HTS detection assay for the determination of SARS-CoV-2 blocking reagents.

AdipoGen has detection of soluble ACE2, antibodies against SARS-CoV-2 and a HTS detection kit for the determination of SARS-CoV-2 blocking reagents.

To date, there are no effective vaccines against coronavirus, which can cause pneumonia & bronchitis, but several strategies are being pursued.

ACE2 was identified as a key receptor on target cells for SARS-CoV in 2002. ACE2 is the entry receptor of SARS-CoV-2 & is the cause of COVID-19.
Caltag Medsystems offers Mobilised LEUKOMAX® Leukopak units from healthy, normal human donors. Through the process, donors are prepped with injections of G-CSF (Granulocyte-Colony Stimulating Factor – also known as Neupogen®), Plerixafor (also known as Mozobil®) or a combination of the
We are pleased to announce that we now have access to COVID-19 specimens including blood-derived specimens from confirmed COVID-19 positive donors and recovered donors. Specimen Types Available: – Nasal, nasopharyngeal and throat swabs – Saliva and sputum – Blood-derived biofluids